Taking on analysts’ expectations and winning: Neogenomics Inc. (NEO)

With 0.65 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.98 million shares. The 52-week range on NEO shows that it touched its highest point at $21.22 and its lowest point at $11.03 during that stretch. It currently has a 1-year price target of $21.70. Beta for the stock currently stands at 1.09.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NEO was up-trending over the past week, with a rise of 1.18%, but this was down by -1.35% over a month. Three-month performance dropped to -8.34% while six-month performance rose 23.02%. The stock lost -12.46% in the past year, while it has lost -4.88% so far this year. A look at the trailing 12-month EPS for NEO yields -0.70 with Next year EPS estimates of 0.14. For the next quarter, that number is -0.04. This implies an EPS growth rate of 97.05% for this year and 4030.19% for next year.

Float and Shares Shorts:

At present, 127.37 million NEO shares are outstanding with a float of 126.12 million shares on hand for trading. On Mar 15, 2024, short shares totaled 7.29 million, which was 5.71% higher than short shares on Feb 15, 2024. In addition to NIO as the firm’s NIO Inc., NEM serves as its Newmont Corporation.

Institutional Ownership:

Through their ownership of 100.86% of NEO’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NEO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, NEO has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and NEO currently yields $0.00. In the past year, NEO’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, NEO has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.